Average Co-Inventor Count = 6.62
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astrazeneca Ab (14 from 1,500 patents)
2. Bayer Schering Pharma Ag (3 from 192 patents)
3. Bayer Pharma Aktiengesellschaft (2 from 378 patents)
4. Astazeneca Ab (1 from 2 patents)
15 patents:
1. 11897869 - JAK1 selective inhibitors
2. 10196374 - 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as SGRM modulators
3. 9512110 - Phenyl and benzodioxinyl substituted indazoles derivatives
4. 8916600 - Phenyl and benzodioxinyl substituted indazoles derivatives
5. 8211930 - Phenyl and benzodioxinyl substituted indazoles derivatives
6. 8153673 - Metalloproteinase inhibitors
7. 8143290 - Chemical compounds 572
8. 7998984 - 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
9. 7754750 - Metalloproteinase inhibitors
10. 7728030 - Chemical compounds 572
11. 7666892 - Metalloproteinase inhibitors
12. 7625934 - Metalloproteinase inhibitors
13. 7427631 - Metalloproteinase inhibitors
14. 7368465 - Metalloproteinase inhibitors
15. 7132434 - Metalloproteinase inhibitors